Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. Until today this year the stock’s price performance recorded an increase of 32.80%. However, over the last six months, the performance has been weaker by 44.92%. The price of DVAX decreased -1.60% over the last 30 days. And in the last five days, it has surged by 2.61%.
Dynavax Technologies Corporation (DVAX) stock is currently valued at $14.13. During the last session, the stock experienced a remarkable rise, reaching $14.19 after opening at $13.79. The stock briefly dropped to $13.67 before ultimately closing at $13.68.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Dynavax Technologies Corporation’s market performance has been stable in recent times. The company’s stock hit a 1-year high of $15.12 on 08/08/23 and a low of $9.42 for the same time frame on 03/17/23.
52-week price history of DVAX Stock
Examining the 52-week high and low prices can provide valuable insights into a stock’s current status and future performance. Dynavax Technologies Corporation’s current trading price is -6.55% away from its 52-week high, while its distance from the 52-week low is 50.00%. The stock’s price range during this time has been between $9.42 and $15.12. The trading volume for the Healthcare sector company’s shares reached about 1.98 million for the day, which was higher than the average daily volume of 1.83 million over the last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Dynavax Technologies Corporation (DVAX) has experienced a quarterly rise of 11.97% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.87B and boasts a workforce of 351 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 12.89, with a change in price of +3.11. Similarly, Dynavax Technologies Corporation recorded 1,621,674 in trading volume during the last 100 days, posting a change of +28.22%.
DVAX’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for DVAX stands at 0.38. Similarly, the long-term debt-to-equity ratio is also 0.38.
DVAX Stock Stochastic Average
Today’s raw stochastic average for Dynavax Technologies Corporation over the last 50 days is 65.26%.This indicates a increase from the raw stochastic average of the past 20 days, which was 49.35%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 30.92% and 20.94%, respectively.
